As of Aug 29
| -0.0701 / -3.05%|
The 2 analysts offering 12-month price forecasts for Windtree Therapeutics Inc have a median target of 5.65, with a high estimate of 8.00 and a low estimate of 3.30. The median estimate represents a +153.37% increase from the last price of 2.23.
The current consensus among 2 polled investment analysts is to Buy stock in Windtree Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.